Chandra Bhagat Pharma Limited Receivables

The latest receivables for CBPL.BO is $760M as of March 2026. That compares with $950M in the prior-year period — down 19.7% year over year. Investors often review this figure alongside Chandra Bhagat Pharma Limited's historical trend and sector peers before judging valuation or financial health.

Over the past year, CBPL.BO's receivables moved from $950M to $760M — a 19.7% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Chandra Bhagat Pharma Limited's operating scale or balance-sheet position.

A receivables figure of $760M for CBPL.BO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting CBPL.BO's receivables ($760M), review year-over-year change from $950M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.